Augurex Life Sciences Corp

VANCOUVER, British Columbia, May 28, 2011 - - Company's Novel Biomarker and Drug Target Could Represent the First Personalized Medicine in RA-Promise for Future Targeted Therapy in a Multi-factorial Disease Augurex Life Sciences Corp.